Colossal Biosciences, a Texas-based company, is on a mission to resurrect extinct species like the dodo and mammoth. With advanced technology and a focused approach, they are confident in their ability to achieve this groundbreaking feat. Discover how they plan to replicate the genes of these extinct animals and the challenges they face in bringing them back to life.
Colossal Biosciences: Reviving Extinct Species with Advanced Technology
( Credit to: Moreradio )
Colossal Biosciences, a Texas-based company, is on a mission to resurrect extinct species like the dodo and mammoth. With advanced technology and a focused approach, they are confident in their ability to achieve this groundbreaking feat.
Utilizing artificial intelligence and other tools, Colossal Biosciences identifies the genes that define an extinct animal and replicates them using the DNA of a closely related existing species. This process, often referred to as 'reverse Jurassic Park,' allows them to bring back these magnificent creatures.
However, the company faces practical challenges in birthing these resurrected animals. For instance, the mammoth project requires finding a way to gestate the animal, a process that takes approximately 22 months. The dodo project involves using surrogate chickens, with the cultivation of primordial germ cells being the most challenging aspect.
Overcoming Hurdles: Challenges in Bringing Back Extinct Species
Bringing back extinct species like the dodo and mammoth is no easy task. Colossal Biosciences must overcome various challenges specific to each project. The mammoth project, for example, faces the obstacle of gestation, which takes around 22 months. On the other hand, the dodo project involves the cultivation of primordial germ cells using surrogate chickens.
Despite these challenges, Colossal Biosciences remains committed to their mission. They are well into the editing phase and are optimistic about the possibility of bringing back mammoths by 2028.
Collaboration and Conservation: Preparing for the Return of Extinct Species
Colossal Biosciences is not only focused on bringing back extinct species but also on ensuring their successful reintegration into the wild. They are collaborating with various stakeholders, including local governments, conservation groups, indigenous communities, private landowners, and the public, to prepare for the animals' return to their natural habitats.
The ultimate goal of Colossal Biosciences is to release all the animals they create back into the wild. By working together with different organizations and communities, they aim to preserve biodiversity and protect nature.
Beyond De-Extinction: Addressing Global Issues and Collaborative Research
Colossal Biosciences' work extends beyond de-extinction. They are actively collaborating with Dr. Paul Ling at Baylor College of Medicine to develop a vaccine against the deadly EEHV virus, which claims the lives of approximately 20% of baby elephants each year.
Additionally, they are partnering with the University of Alaska and the University of Stockholm on radiocarbon dating and genome sequencing of American mammoths, marking the largest study of its kind. Through their research and collaborations, Colossal Biosciences aims to address pressing global issues, including the decline in biodiversity.
Colossal Biosciences: Pioneering De-Extinction and Preserving Biodiversity
Colossal Biosciences is at the forefront of the field of de-extinction, with plans to bring back extinct species such as the dodo and mammoth. With the necessary technology and a focused approach, they are confident in their ability to achieve these groundbreaking feats.
While there are challenges to overcome, from genetic replication to finding suitable environments for the revived creatures, Colossal Biosciences remains committed to its mission of preserving biodiversity and utilizing innovative tools to protect nature.
Through their work, they hope to contribute to the fight against the decline in biodiversity and provide innovative solutions for conservation efforts.
